Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Edoxaban on Platelet Aggregation in Stable CAD
NCT05122455Phase 3Completed
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of edoxaban in coronary artery disease (CAD), sponsored by Universidade de São Paulo. Primary endpoint: Platelet aggregability using Multiplate-TRAP at Day 10. Started Sep 2021; status: completed.
02
Drugs
edoxaban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05122455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122455.